Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence Monitoring in NSCLC Using Circulating Tumor DNA

NCT03878537 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.

NCT NCT03878537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence Monitoring in NSCLC Using Circulating Tumor DNA
Lead sponsor
Scripps Translational Science Institute
Phase
Observational
Overall status
Unknown status
Start date
March 14, 2019
Completion date
December 31, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer